Ulla Westin (Former)
1 – 32 of 32
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Limited beneficial effects of systemic steroids when added to standard of care treatment of seasonal allergic rhinitis
(
- Contribution to journal › Article
- 2022
-
Mark
High dose pollen intralymphatic immunotherapy : Two RDBPC trials question the benefit of dose increase
(
- Contribution to journal › Article
- 2020
-
Mark
A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy
(
- Contribution to journal › Article
- 2019
-
Mark
Intralymphatic Immunotherapy : Update and Unmet Needs
(
- Contribution to journal › Article
- 2018
-
Mark
KUL fyller i kunskapsluckor
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass : A randomized, double-blind, placebo-controlled trial
(
- Contribution to journal › Letter
-
Mark
Voice and swallowing after total laryngectomy
(
- Contribution to journal › Article
- 2017
-
Mark
The Pharyngoesophageal Segment after Total Laryngectomy
(
- Contribution to journal › Article
-
Mark
Measured adiposity in relation to head and neck cancer risk in the European Prospective Investigation into Cancer and Nutrition
2017) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 26(6). p.895-904(
- Contribution to journal › Article
- 2016
-
Mark
Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.
(
- Contribution to journal › Article
-
Mark
Combined effects of smoking and HPV16 in oropharyngeal cancer
(
- Contribution to journal › Article
-
Mark
Novel strategies for the treatment of grass pollen-induced allergic rhinitis
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Treatment of cricopharyngeal dysfunction: a comparative pilot study.
(
- Contribution to journal › Article
- 2014
-
Mark
Allergen-specific immunotherapy increases plasma gelsolin levels
(
- Contribution to journal › Article
- 2013
-
Mark
Intralymphatic allergen-specific immunotherapy: An effective and safe alternative treatment route for pollen-induced allergic rhinitis
(
- Contribution to journal › Article
- 2012
-
Mark
Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor.
(
- Contribution to journal › Article
- 2011
-
Mark
Secretory Leukocyte Protease Inhibitor inhibits neutrophil apoptosis.
(
- Contribution to journal › Article
- 2008
-
Mark
An association between Type 2 diabetes and alpha(1)-antitrypsin deficiency
(
- Contribution to journal › Article
- 2007
-
Mark
Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma
(
- Contribution to journal › Article
-
Mark
Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
(
- Contribution to journal › Article
- 2006
-
Mark
Secreted leukocyte protease inhibitor is present in aqueous humours from cataracts and other eye pathologies.
(
- Contribution to journal › Article
- 2005
-
Mark
Prolastin, a pharmaceutical preparation of purified human alpha 1-antitrypsin, blocks endotoxin-mediated cytokine release
(
- Contribution to journal › Article
- 2004
-
Mark
Increased plasma levels of serine proteinase inhibitors in lung cancer patients.
(
- Contribution to journal › Article
-
Mark
αl-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro
(
- Contribution to journal › Article
- 2003
-
Mark
Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro.
(
- Contribution to journal › Article
- 2002
-
Mark
The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation.
(
- Contribution to journal › Article
- 2001
-
Mark
Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa
(
- Contribution to journal › Article
- 2000
-
Mark
Experimental and Clinical Studies of SLPI, with Special Reference to IgE-Mediated Allergic Reactions
2000)(
- Thesis › Doctoral thesis (compilation)
- 1999
-
Mark
The effect of immediate-hypersensitivity reactions on the level of SLPI, granulocyte elastase, α1-antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge
(
- Contribution to journal › Article
-
Mark
Identification of SLPI (Secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation
(
- Contribution to journal › Article
- 1998
-
Mark
IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release
(
- Contribution to journal › Article
- 1994
-
Mark
Localisation of secretory leucocyte proteinase inhibitor mRNA in nasal mucosa
(
- Contribution to journal › Article